No abstract available
Keywords:
COVID-19; Coronavirus; SARS-CoV-2; mutant strain; mutant virus; vaccine; variant virus.
Publication types
-
Editorial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
COVID-19 / prevention & control*
-
COVID-19 / transmission
-
COVID-19 Vaccines*
-
Humans
-
SARS-CoV-2 / pathogenicity*
-
Spike Glycoprotein, Coronavirus / genetics
Substances
-
COVID-19 Vaccines
-
Spike Glycoprotein, Coronavirus
-
spike protein, SARS-CoV-2
Grants and funding
This article was supported in part by the funds of the Place Based Planetary Health Grant PH098 to VA from VU Research, Victoria University.